04/04/2024
3:54 PM | Galmed Pharmaceuticals (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/15/2024
8:13 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
1:14 PM | CVI Investments, Inc. (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
8:52 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/29/2023
11:15 PM | Galmed Pharmaceuticals (Filer)
| Form EFFECT | |
11/22/2023
3:48 PM | Galmed Pharmaceuticals (Filer)
| Form POS AM | |
11/20/2023
3:37 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2023
7:51 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/22/2023
3:15 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/21/2023
6:30 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K/A | |
09/20/2023
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/21/2023
9:12 AM | CVI Investments, Inc. (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G | |
07/18/2023
8:23 AM | Galmed Pharmaceuticals (Filer)
| Form 424B4 | |
07/18/2023
8:25 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/16/2023
11:15 PM | Galmed Pharmaceuticals (Filer)
| Form EFFECT | |
07/14/2023
8:44 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/13/2023
4:08 PM | Galmed Pharmaceuticals (Filer)
| Form F-1/A | |
07/12/2023
4:29 PM | Galmed Pharmaceuticals (Filer)
| Form F-1/A | |
07/10/2023
7:10 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2023
7:37 AM | Galmed Pharmaceuticals (Filer)
| Form F-1/A | |
06/28/2023
7:40 AM | Galmed Pharmaceuticals (Subject)
| Form FWP | |
06/01/2023
7:14 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2023
6:00 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2023
6:14 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
